Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kurtipek, M. çayci, N. Düzgün, H. Esme, S. Baktik, M. S. Aygün, Y. Ünlü, C. Burnik, T. T. Bekçi, Y. Terzi (Konya, Samsun, Turkey). Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer. Eur Respir J 2014; 44: Suppl. 58, 347

Member's Comments

No comment yet.

Related content which might interest you: The prognostic value of the tumor shrinkage rate for progression-free survival in patients with non-small cell lung cancer receiving gefitinib Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Algorithm of preoperative N-staging of non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Prognostic value of preoperative C-reactive protein in resectable non-small cell lung cancer - 5-years prospective study Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Prognostic factors for survival in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Locoregional recurrence after pulmonary segmentectomy of non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Clinical profile and survival of patients undergoing surgery for non-small cell lung cancer: Impact of positron emission tomography adoption Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 EBUS-TBNA for nodal restaging and relapse in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Neutrophil/lymphocyte ratio as a prognostic marker for curative-intent surgery in non-small cell lung cancer Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 The role of second line chemotherapy in small cell lung cancer: A retrospective analysis Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015